REFRACTORY NEUROBLASTOMA
Clinical trials for REFRACTORY NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for REFRACTORY NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double immune attack: new cell combo targets tough childhood cancers
Disease control Not yet recruitingThis early-phase study tests a new combination of two types of immune cells—NK cells and CAR-T cells—for people whose neuroblastoma or osteosarcoma has returned or not responded to standard treatments. The cells are modified to better recognize and fight cancer and to survive lon…
Matched conditions: REFRACTORY NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
New hope for kids with tough neuroblastoma: drug combo trial launches
Disease control Not yet recruitingThis study tests whether adding iberdomide to standard chemoimmunotherapy is safe and works better for children and young adults (ages 1–30) with neuroblastoma that has come back or not responded to prior treatment. About 76 participants will receive either the standard treatment…
Matched conditions: REFRACTORY NEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 04, 2026 16:22 UTC